Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
RXRX Quote, Financials, Valuation and Earnings
Last price:
$6.11
Seasonality move
:
-20.8%
Day range:
$5.46 - $5.74
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
29.16x
P/B ratio:
2.40x
Volume:
27.5M
Avg. volume:
32.2M
1-year change:
-33.89%
Market cap:
$2.2B
Revenue:
$58.5M
EPS (TTM):
-$1.77
Recursion Pharmaceuticals Number of Institutional Trades
Recursion Pharmaceuticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$3.4B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.6B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Recursion Pharmaceuticals Institutional Ownership
-
What Percentage Of RXRX Is Owned by Institutions?
-- of RXRX is owned by institutions.
-
How Many Institutions Own RXRX Shares?
Recursion Pharmaceuticals stock is owned by 612 institutional shareholders at this time.
-
Have Institutions Been Buying RXRX Stock?
Yes, institutions have bought 264.7M shares of RXRX in the last quarter.
-
Have Institutions Been Selling RXRX Stock?
Yes, institutions have sold 142.2M shares of RXRX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.65% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 8.52% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
